Matches in Nanopublications for { <http://bio2rdf.org/drugbank_resource:DB01218_DB06708> ?p ?o ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- drugbank_resource:DB01218_DB06708 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB01218_DB06708 label "DDI between Halofantrine and Lumefantrine - Halofantrine may increase the adverse effects of lumefantrine. Additive QTc-prolongation may occur. Combination therapy is contraindicated and therapies should not be administered within one month of each other due to the long half-life of lumefantrine. [drugbank_resource:DB01218_DB06708]" assertion.
- drugbank_resource:DB01218_DB06708 identifier "drugbank_resource:DB01218_DB06708" assertion.
- drugbank_resource:DB01218_DB06708 title "DDI between Halofantrine and Lumefantrine - Halofantrine may increase the adverse effects of lumefantrine. Additive QTc-prolongation may occur. Combination therapy is contraindicated and therapies should not be administered within one month of each other due to the long half-life of lumefantrine." assertion.